INTS8 rs10100651: Stress Response & PTSD Genetics
The rs10100651 polymorphism is an intronic single nucleotide variant located within the INTS8 gene on chromosome 8. Multivariate genome-wide association studies have identified this locus in connection with stress-related quantitative phenotypes and post-traumatic stress disorder (PTSD) risk. Carrying this variant reflects a subtle statistical difference in population-level stress vulnerability rather than an absolute medical diagnosis.
What each genotype means
Typical stress response profile
This genotype represents the most common genetic configuration at this location in many populations. Research suggests this variant is associated with stress-related quantitative phenotypes, but carrying this specific version does not imply a diagnosis or a specific clinical outcome. Stress resilience is influenced by a complex interplay of many genetic and environmental factors.
This is the most common genotype in populations of European ancestry, carried by approximately 42% of individuals.
Varied stress response profile
Individuals with this genotype carry one copy of the variant associated with stress-related phenotypes in large-scale genetic studies. While this variant has been linked to PTSD risk in research, it is only one of many factors that contribute to how an individual processes stress. This result should not be used to predict personal health outcomes or diagnose any condition.
This heterozygous genotype is found in roughly 45% of individuals of European ancestry.
Increased stress sensitivity marker
This genotype includes two copies of the variant identified in genome-wide association studies as being linked to stress-related quantitative phenotypes and PTSD risk. Because this association is based on statistical trends across large populations, it does not determine an individual's personal risk or mental health status. Many other genetic and life factors play a much larger role in determining how someone responds to stress.
This genotype is the least common of the three, appearing in approximately 13% of individuals of European ancestry.
Genomic Location and Variant Characteristics
The single nucleotide polymorphism rs10100651 is situated on chromosome 8 (at position 8:94874997 in recent genome builds) inside an intron of the INTS8 gene. Because it falls within a non-coding intronic region, it does not directly alter the amino acid sequence of the encoded protein. Instead, non-coding variants of this type often exert their effects by modulating gene expression, altering splicing dynamics, or acting as linkage markers for nearby regulatory elements. Public resources such as the GWAS Catalog and dbSNP catalog rs10100651 as a common biallelic variant involving thymine (T) and cytosine (C) alleles. Researchers examine such variants to explore how non-coding genomic differences can correlate with downstream physiological traits.
Biological Role of the INTS8 Gene
The INTS8 gene encodes subunit 8 of the multi-protein Integrator complex, an essential cellular machine associated with RNA polymerase II. The Integrator complex plays a central role in the 3'-end processing of small nuclear RNAs (snRNAs U1 and U2), transcriptional termination, and broader messenger RNA maturation across tissues. Deeply conserved in eukaryotes, INTS8 is widely expressed throughout the central nervous system. Severe loss-of-function disruptions in INTS8 have been cataloged in OMIM and ClinVar in connection with rare neurodevelopmental syndromes, illustrating the gene's fundamental necessity in healthy brain development. When studying common intronic variants like rs10100651, scientists investigate whether subtle shifts in INTS8-mediated transcriptional regulation influence biological resilience to acute and chronic psychological trauma.
Research Associations: Stress Response and PTSD
Interest in rs10100651 arises primarily from large-scale multivariate genome-wide association analyses exploring quantitative traits related to traumatic stress, emotional processing, and post-traumatic stress disorder (PTSD). In these population-level studies, rs10100651 reached suggestive to genome-wide significance across stress symptom score cohorts. However, the overall strength of evidence is classified as moderate. Psychiatric phenotypes are profoundly polygenic, shaped by thousands of common genetic loci each contributing an incremental fraction of risk. Possessing the risk allele does not imply clinical PTSD, nor does its absence guarantee immunity. Moreover, environmental factors such as trauma severity, childhood adversity, social support networks, and epigenetic modifications play decisive roles in clinical stress outcomes.
Population Frequency and Ancestry Patterns
Variant rs10100651 is widely observed in human populations, exhibiting varying allele frequencies across global demographic groups documented in gnomAD. In populations of European ancestry, the minor allele frequency is approximately 0.35, making both the heterozygous and homozygous forms common. Because allele distributions fluctuate between different ancestral lineages, effect sizes observed in European cohorts cannot automatically be generalized to individuals of African, East Asian, or Hispanic backgrounds. Comprehensive biobanks and global consortia continue to characterize rs10100651 across diverse ancestries to refine how its statistical associations behave in different genomic and environmental contexts.
What You Can and Cannot Conclude from This Variant
Viewing your rs10100651 genotype provides insight into one small strand of your complex genetic architecture, but it has important limitations. A genotype at rs10100651 is not a clinical diagnosis of PTSD, an anxiety disorder, or any neurological condition. Because mental health phenotypes are multi-factorial, genetic testing should never be used as a standalone diagnostic tool or as a reason to alter psychological treatment. If you are experiencing distress, chronic stress, or symptoms of trauma, consult a qualified mental health clinician or physician. Similarly, if you are taking prescription medications for anxiety, depression, or sleep, any questions about response or dosing should be reviewed with your prescribing clinician or pharmacist.
How common is this variant?
The minor allele frequency for rs10100651 is approximately 0.35 in populations of European ancestry, making both heterozygous and homozygous variant genotypes common across the general population.
Frequently asked questions
Does having the rs10100651 risk genotype mean I will develop PTSD?
No. The variant confers only a small statistical influence identified in large population studies. Complex psychiatric conditions like PTSD require traumatic environmental exposure and involve thousands of interacting genes, lifestyle factors, and psychological coping mechanisms.
What is the biological function of the INTS8 gene?
INTS8 produces subunit 8 of the Integrator complex, which coordinates with RNA polymerase II to process small nuclear RNAs (snRNAs) and regulate RNA transcription. It is critical for normal cellular function and central nervous system development.
Can rs10100651 guide my psychiatric medication choices?
No, rs10100651 is not a pharmacogenomic marker and is not used to guide drug selection or dosage. Any questions regarding stress or psychiatric medications should always be discussed directly with your healthcare provider or pharmacist.
Why do different genetic testing reports show different risk alleles for rs10100651?
DNA consists of complementary forward and reverse strands, meaning a variant reported as C on one strand corresponds to G on the other, or T corresponds to A. Minor reporting differences depend on the genome build and strand orientation used by the testing platform.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10100651?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29